203 related articles for article (PubMed ID: 24127122)
21. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.
Huang W; Zhang Y; Varambally S; Chinnaiyan AM; Banerjee M; Merajver SD; Kleer CG
Am J Pathol; 2008 Apr; 172(4):893-904. PubMed ID: 18321996
[TBL] [Abstract][Full Text] [Related]
22. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
[TBL] [Abstract][Full Text] [Related]
23. High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer.
Zhang C; Han Y; Huang H; Qu L; Shou C
Breast Cancer Res Treat; 2014 Sep; 147(2):265-81. PubMed ID: 25129343
[TBL] [Abstract][Full Text] [Related]
24. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J
Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922
[TBL] [Abstract][Full Text] [Related]
25. miRNA‑490‑3p promotes the metastatic progression of invasive ductal carcinoma.
Lu N; Zhang M; Lu L; Liu YZ; Zhang HH; Liu XD
Oncol Rep; 2021 Feb; 45(2):706-716. PubMed ID: 33416185
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer.
Nagai MA; Gerhard R; Salaorni S; Fregnani JH; Nonogaki S; Netto MM; Soares FA
Int J Oncol; 2010 Jul; 37(1):41-9. PubMed ID: 20514395
[TBL] [Abstract][Full Text] [Related]
27. Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.
Tan R; Wang L; Song J; Li J; He T
J Cancer Res Ther; 2017; 13(4):707-714. PubMed ID: 28901319
[TBL] [Abstract][Full Text] [Related]
28. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
Teo WW; Merino VF; Cho S; Korangath P; Liang X; Wu RC; Neumann NM; Ewald AJ; Sukumar S
Oncogene; 2016 Oct; 35(42):5539-5551. PubMed ID: 27157614
[TBL] [Abstract][Full Text] [Related]
29. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
[TBL] [Abstract][Full Text] [Related]
31. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
32. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
[TBL] [Abstract][Full Text] [Related]
35. PIP4K2B: Coupling GTP Sensing to PtdIns5P Levels to Regulate Tumorigenesis.
Fiume R; Jones DR; Divecha N
Trends Biochem Sci; 2016 Jun; 41(6):473-475. PubMed ID: 27132569
[TBL] [Abstract][Full Text] [Related]
36. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.
Lapyckyj L; Castillo LF; Matos ML; Gabrielli NM; Lüthy IA; Vazquez-Levin MH
J Cell Physiol; 2010 Mar; 222(3):596-605. PubMed ID: 19957299
[TBL] [Abstract][Full Text] [Related]
37. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
38. Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.
Pandey V; Wu ZS; Zhang M; Li R; Zhang J; Zhu T; Lobie PE
Breast Cancer Res; 2014 Sep; 16(5):429. PubMed ID: 25266665
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
40. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.
Dong C; Wu Y; Yao J; Wang Y; Yu Y; Rychahou PG; Evers BM; Zhou BP
J Clin Invest; 2012 Apr; 122(4):1469-86. PubMed ID: 22406531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]